Delivery Order SPE2DB22D3301-SPE2DB24FZ3BS
Award Date
8/16/24
Potential Completion Date
9/9/24
Potential Value
$2.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) is for the delivery of Envarsus XR 4 mg tablets. The $3,230.68 firm-fixed-price delivery order has an ultimate completion date of October 15, 2024 and was awarded on September 23, 2024. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) for the delivery of Envarsus XR 4 mg tablets. The contract has a ceiling value of $1,671.16 and a completion date of January 2, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen is a for-profit organization registered in the System for Award...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,806.66 firm fixed-price contract is for the supply of Envarsus XR 1 mg tablets, a specialty medication. The contract has a period of performance through February 25, 2025 and was not set aside for any specific business category. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of Envarsus XR 1 mg tablets to the Defense Logistics Agency (DLA). The fixed-price delivery order has a potential value of $1,216.11 and a completion date of March 4, 2024. Amerisourcebergen Drug Corp, a for-profit organization, serves as the prime contractor for this contract, which is not designated as a set-aside. The company holds an indefinite delivery contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, for the delivery of Envarsus XR 1 mg tablets. The contract, valued at $1,216.11, is a firm fixed-price delivery order with a period of performance through July 5, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $3,230.68, is for the delivery of Envarsus XR 4 mg tablets, a prescription medication. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is July 18, 2024. This award is not associated with any set-aside designation. AmerisourceBergen Drug Corp, a major supplier of pharmaceutical...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of Envarsus XR 1 mg tablets, a pharmaceutical product, to the U.S. government. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a part of the Department of Defense (DoD), with a ceiling value of $1,465.68. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,216.11, is for the supply of Envarsus XR 1 MG tablets. This order is placed under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC covers a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division provides for the delivery of the pharmaceutical product Envarsus XR 1 mg tablet to the U.S. government. The $1,465.68 firm fixed price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical and has a completion date of May 6, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to federal agencies, particularly the Department of Defense (DoD) and...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Envarsus XR 1 mg tablets. The Firm Fixed Price delivery order has a ceiling value of $1,216.11 and a period of performance through July 29, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999.00 through December 31, 2025. This single-award IDC...